Introduction {#S1}
============

Pseudoxanthoma elasticum (PXE) is a hereditary disease caused primarily by mutations in the ABCC6 gene ([@R1]; [@R16], [@R30]), yet the mechanisms leading to elastic fiber mineralization and consequently to clinical manifestations are not well understood. A number of hypotheses have been proposed in order to explain how lack or impaired function of ABCC6, a transmembrane transporter protein, almost exclusively expressed in the liver, can cause alterations in peripheral soft connective tissues, including elastic fiber calcification in the skin, eyes and the arterial blood vessels ([@R26]; [@R19]). It has been proposed that ABCC6 transporter deficiency may alter the availability of circulating factors, presumably metabolized and secreted by the liver, which are physiologically required to prevent aberrant calcifications and are able to modulate the phenotype of mesenchymal cells, such as fibroblasts ([@R31]). As a consequence of fibroblasts' abnormal protein profile ([@R4]), extracellular matrix components are differentially synthesized and/or degraded and elastic fiber mineralization ensues ([@R7], [@R25]; [@R27]; [@R10]). Alternatively, it has been suggested that, serum factors controlling soft connective tissue calcification are abnormally secreted by the liver and cause the calcification of elastic fibers. If this is the case, changes in the characteristics of mesenchymal cells could represent a secondary response to the mineralized environment ([@R17]). A number of studies has been performed demonstrating that PXE fibroblasts, even though isolated from patient's tissues and cultured in an optimal in vitro environment, maintain a number of characteristics that clearly discriminate pathologic from healthy cells ([@R31]). Nevertheless, it is currently unclear which changes in fibroblasts occur before mineralization of elastic fibers and might be considered pathogenic for calcification, and which changes represent the cellular response to the mineralized environment. So far, all in vitro investigations on PXE have been performed on fibroblasts isolated and cultured from patients, i.e., from individuals who have been diagnosed on the basis of clinical manifestations as a consequence of calcification. Taking advantage of the PXE animal model, which recapitulates the PXE phenotype, including the slow progression of tissue mineralization ([@R12]; [@R14]), the aim of this study was to compare fibroblasts from congenic Abcc6^−/−^ (KO) and Abc6^+/+^ (WT) mice. Since calcification in these animals occurs only after 5--6 weeks of age ([@R14]), fibroblasts were isolated from KO and WT mice at the age of 0.5 (absence of calcification) and 12 months (presence of calcification). A set of cellular parameters we have previously shown to be altered in dermal fibroblasts from PXE patients and to be related to the mineralization have been investigated ([@R4]; [@R2]). Therefore, cells were characterized for their proliferative capabilities and for their redox balance ([@R28]; [@R24]), looking at the intracellular content of reactive oxygen species (ROS). Moreover, the expression of proteins exerting a key role on the development of ectopic calcification ([@R11]), such as bone morphogenic protein 2 (Bmp2), osteopontin (Opn), pyrophosphatase/phosphodiesterase 1 (Enpp1), progressive ankylosis protein (Ank), and tissue non-specific alkaline phosphatase (Tnap), was evaluated by Western blot analysis and Tnap activity ([@R2]) was assessed by spectrophotometry.

Results {#S2}
=======

Fibroblast proliferation capabilities {#S3}
-------------------------------------

The number of fibroblasts that can be isolated from the skin of mice is progressively lower with advancing age, and therefore a higher number of adult animals was necessary in order to avoid differences in the number of population doublings of fibroblasts from young and older animals during all experimental procedures. In contrast to human dermal fibroblasts, murine cells reach senescence around passage 4. Therefore, fibroblasts, independently from their genotype, were studied only at passages 2 to 3. Nevertheless, fibroblasts isolated from the skin of adult mice have a lower capacity to replicate in vitro compared to cells from younger animals and, when observed by phase contrast microscopy, appeared larger with cytoplasmic vacuoles ([Figure 1A](#F1){ref-type="fig"}). Differences in the proliferation capabilities were independent from the genotype but were clearly related to animal's age ([Figure 1 B](#F1){ref-type="fig"}).

Intracellular ROS content {#S4}
-------------------------

Since aging is characterized by an altered redox balance and an oxidative stress has been demonstrated in PXE either in vitro or in vivo, both in patients and in animal models ([@R24]; [@R9]; [@R20]), the intracellular ROS content was evaluated in mouse fibroblasts. [Figure 2](#F2){ref-type="fig"} shows that the H~2~O~2~ content is not affected by age nor by the genotype. Interestingly, there was no difference in the amount of superoxide anion in fibroblasts from young WT and KO mice, whereas there was a significant increase in O~2~^−^ in fibroblasts from adult Abcc6^−/−^ mice compared to cells grown from WT animals of the same age or from younger Abcc6^−/−^ mice ([Figure 2](#F2){ref-type="fig"}).

Protein expression {#S5}
------------------

No differences in Bmp2 expression were observed in young WT and KO animals (i.e. before the occurrence of calcification). With age, a significant upregulation was observed only in cells grown from adult KO animals ([Figure 3](#F3){ref-type="fig"}).

Evaluation of Tnap protein expression revealed a significant increase with mice age, without differences between WT and KO animals ([Figure 4](#F4){ref-type="fig"}). Similarly, Tnap activity was significantly upregulated in fibroblasts from adult compared to younger mice ([Figure 4](#F4){ref-type="fig"}). Moreover, enzymatic activity was even higher (p\<0.05) in cells from adult KO mice compared to WT mice of the same age ([Figure 4](#F4){ref-type="fig"}).

In murine dermal fibroblasts, Enpp1 expression was significantly decreased in adult mice as compared to young animals, however, no differences were observed between Abcc6^−/−^ and Abcc6^+/+^ mice ([Figure 5](#F5){ref-type="fig"}).

On the contrary, Abcc6^−/−^ mice, at all ages, were characterized by a significantly lower expression of Ank compared to WT animals. However, no changes were noted between cells from young and adult animals ([Figure 5](#F5){ref-type="fig"}), indicating that this protein is not affected by animal's age.

Osteopontin, a well known inhibitor of the calcification process, was significantly reduced in Abcc6^−/−^ fibroblasts compared to cells from age-matched WT mice. Differences were negligible with age ([Figure 6](#F6){ref-type="fig"}), indicating that mouse genotype is the main regulator of Opn expression.

Conclusions {#S6}
===========

While we have made significant progress in understanding the molecular basis of PXE, pathogenic mechanisms responsible for the calcification of elastic fibers in this disease remain to be clarified. Our understanding of PXE has been improved by the development of transgenic mouse models by specifically inactivating the Abcc6 gene ([@R14]; [@R12]). Consistently, Abcc6^−/−^ mice recapitulate several histopathological findings typical of PXE patients, including the slowly progressive mineralization of connective tissues in the skin, eyes and the arterial blood vessels ([@R14]; [@R13]). The aim of this study was to investigate fibroblasts isolated from the skin of Abcc6^−/−^ and Abcc6^+/+^ mice. Moreover, animals of two different ages were used in order to compare the behavior of cells before and after the onset of calcification. The present study design can identify changes which, when preceding ectopic mineralization, could contribute to the development of pathologic calcification, as well as differences that, when observed after the occurrence of mineralization, are possibly induced by the modified environment. In order to exclude changes simply related to the animal's aging, we have compared age-matched WT and KO mice ([Table 1](#T1){ref-type="table"}). The choice of this model was predicated upon a number of reasons: a) The mouse model allows the analysis of cells from tissues before animals with the Abcc6^−/−^ genotype develop calcification, a condition that cannot be evaluated in humans since the histopathological diagnosis of PXE is routinely made after the onset of clinical manifestations, i.e., when the mineral precipitates are already present in tissues; b) Fibroblasts are an excellent model for studying PXE, since they maintain in vitro a pathological phenotype ([@R28], [@R27]) exhibiting oxidative stress parameters ([@R24]) and an altered protein profile ([@R4], [@R2]). In this study, we have investigated the occurrence of oxidative stress and the expression of a number of proteins that are involved in the calcification process and in particular in phosphate-related pathways, as we have hypothesized that they play a key role in the development and/or progression of soft connective tissue calcification in PXE ([@R2]; [@R19]; [@R18]). Our results demonstrated that murine dermal fibroblasts, in contrast to human dermal fibroblasts ([@R3]), exhibit in vitro morphological features and proliferative capabilities that vary dependent on the animal's age, independently of the genotype. Therefore, the absence of the Abcc6 gene activity does not affect the proliferation potential of mesenchymal cells.

Replicative senescence in many in vitro models, including dermal fibroblasts, has been associated with increased ROS content ([@R15]). Altered redox balance is a frequent condition common to many disorders, both in the absence or in the presence of ectopic calcification ([@R6]) and has been demonstrated to be related to the severity of clinical manifestations in patients with PXE and PXE-like disorders ([@R9]; [@R2]). Since only fibroblasts from adult Abcc6^−/−^ mice were shown to have higher levels of O~2~^−^, oxidative stress is likely the consequence of the calcified environment. Consistent with this conclusion, it has been demonstrated in the PXE animal model that antioxidant treatment can ameliorate the redox balance, without affecting the extent of mineralization ([@R20]).

Bmp2 expression is essential for osteoblastic differentiation of mesenchymal cells and therefore it has been widely implicated in the development of vascular calcification ([@R8]). Recent studies have shown that BMP2 is upregulated by ROS, being at the same time an inducer of ROS accumulation ([@R23]) and favoring alkaline phosphatase activity and phosphate accumulation ([@R29]). In accordance, we have shown that Bmp2, in association with ectopic calcification and with ROS accumulation, is significantly upregulated in fibroblasts from adult Abcc6^−/−^ mice. Therefore, these data support the hypothesis that when calcification is initiated, there is a stimulatory loop that further increases mineral deposition and alters the phenotypic behavior of fibroblasts. A key question relates to the factor(s) that are capable of triggering the initial phase of ectopic calcification in specific areas of soft connective tissues. We have already demonstrated that Tnap activity is significantly upregulated in fibroblasts from PXE patients, suggesting that phosphate metabolism plays a role in the pathogenesis of elastic fiber calcification ([@R2]). Present data further indicate that there is an age-dependent upregulation of Tnap expression and Tnap activity in fibroblasts from Abcc6^−/−^ mice. Alkaline phosphatase acts on phosphate-containing substrates by releasing Pi that can accumulate in the extracellular matrix and, under favorable conditions of the microenvironment, can precipitate in the form of hydroxyapatite crystals. One of these substrates is the calcification inhibitor, inorganic pyrophosphate (PPi), which is generated by Enpp1 through hydrolysis of ATP to AMP and PPi, and transported to the extracellular milieu by Ank. Assessment of the expression of these proteins indicated that both the age and the genotype of mice contribute to phenotypic changes of the fibroblasts.

In particular, our data demonstrated that, at all time points, Abcc6^−/−^ fibroblasts have a lower expression of Ank, a protein that is necessary for providing the extracellular environment with adequate amounts of physiological calcification inhibitors, including PPi. When Ank is downregulated, soft connective tissue becomes increasingly prone to mineralization. As this process gradually progresses with increased age of the animals, fibroblasts are modified towards a phenotype that favors mineral precipitation (i.e., lower Enpp1 and increased Tnap expression and activity). These observations are in agreement with the concept that ectopic calcification is more frequently observed in aged individuals.

Interestingly, besides PPi, other factors control mineral deposition in the extracellular matrix, including osteopontin, a well known inhibitor of vascular calcification ([@R32]), as it regulates apatite crystal size and growth most likely by its ability to directly bind to specific apatite crystal faces ([@R33]). The marked down-regulation of Opn expression observed in fibroblasts from Abcc6^−/−^ mice at all ages, together with lower PPi availability and a progressive Tnap-mediated release of Pi from the PPi pool in older mice, may act in synergy to promote mineral deposition.

In this study, a comparison of a number of parameters, before and after the onset of mineral deposition in tissues of PXE mice, demonstrated that there are changes in dermal fibroblasts that can be related to the genotype and that are present well before the development of calcification. Such changes possibly represent a trigger of calcification, whereas other changes may reflect a cellular response to the calcified environment that further sustains the mineralization process. Finally, the observation that Ank expression is significantly reduced in fibroblasts from the young Abcc6^−/−^ mice supports the hypothesis that phosphate metabolism is locally altered in PXE ([@R2]) and that reduced transport of the calcification inhibitor PPi in the extracellular compartment, together with impaired carboxylation of Matrix Gla Protein ([@R10]; [@R21]; [@R2]), may be the key players for the initial deposition of mineral precipitates in the absence of Abcc6 transport activity.

In conclusion, our data demonstrate that, although grown in optimal culture conditions, dermal fibroblasts from KO mice, similar to human PXE fibroblasts, exhibit and maintain in vitro characteristics. Therefore, at least few of the differences in protein expression are related to the genotype, whereas others parameters are modulated both by the genotype and by the age of the animals ([Table 1](#T1){ref-type="table"}). Although it cannot be excluded that circulating factors in vivo exert an epigenetic modulation on fibroblasts' phenotype, the present data support the role of mesenchymal cells, such as fibroblasts in the mineralization process. These cells exhibit a differential expression of molecules related to the calcification process before ectopic calcification takes place within tissues, thus excluding that these changes are the consequence of the mineralized environment. Within this context Ank and Opn may represent two potential pharmacologic targets warranting further investigation in the search for novel therapies for PXE.

Materials and Methods {#S7}
=====================

Cells {#S8}
-----

Dermal fibroblast cultures were obtained from the whole skin of 37 Abcc6^−/−^ and 29 Abcc6^+/+^ mice of 0.5 (n=27) and 12 months (n=39) of age. The study was approved by the Ethical Committee of the University of Modena and Reggio Emilia. Fibroblasts were cultured in DMEM (Gibco, Grand Island, New York, USA) with 10% fetal bovine serum (FBS) (Lonza) and used at 2^nd^ or 3^rd^ passages. During all experimental procedures, fibroblasts were pooled from several animals of the same age and genotype. Cells were routinely cultured in 75cm^2^ flasks (Nunc, Roskilde, Denmark) with DMEM supplemented with 10% FBS, penicillin 100 IU/ml, streptomycin 100 μg/ml and nonessential amino acids 1X (Gibco). Cells were observed by phase contrast microscopy.

Flow Cytometry {#S9}
--------------

ROS analysis was performed on proliferating cells as previously described ([@R4]). Briefly, cells were stained with dihydroethidium (DH~2~, 1 mM) and 2′,7′-dichlorodihydrofluorescein diacetate (H~2~DCF-DA, 2 mM) probes (Molecular Probes, Eugene, OR) for the determination of superoxide anion O~2~^−•^ and hydrogen peroxide (H~2~O~2~), respectively. Cells were analyzed on an EPICS XL flow cytometer (Coulter, USA) at the emission wavelengths of 575 and 520 nm. Ten thousand events were collected and evaluated for each treatment using a WINMDI 2.8 program. Experiments were performed in duplicate and repeated twice.

Western blot {#S10}
------------

Cells were homogenized in RIPA buffer with protease inhibitors (Sigma), centrifuged and supernatants collected and stored at −80°C until analysis. Protein concentration was measured in each sample according to Bradford assay ([@R5]) in order to load equal amounts of protein. After separation by 1D PAGE, proteins were transferred to nitrocellulose and incubated with anti-Ank, anti-Opn, anti-Bmp2 (Abcam, Cambridge-UK); anti-Enpp1; anti-Tnap (Vascular Products, Maastricht, The Netherlands), followed by appropriate horseradish peroxidase (HRP)-conjugated secondary antibodies (Abcam). Experiments were performed at least two times with all different cell lines.

Alkaline phosphatase activity {#S11}
-----------------------------

Fibroblasts were detached by enzymatic treatment and washed three times with PBS. Cells were lysed by appropriate buffer containing 0.1% Triton X-100 (Sigma). Cell lysate (20 μL) was mixed with 100 μL Tris-glycine buffer, pH 10.3 (50 mM Tris-HCl, 100 mM glycine and 2 mM MgCl~2~) and 100 μL of p-nitrophenyl phosphate (Sigma). The reaction mix was incubated at 37°C for 30 min and the reaction stopped by adding 50 μL of 3 M NaOH. Absorbance was measured at 405 nm in a microplate reader. Enzymatic activity was normalized to total protein concentration using bovine serum albumin as a standard for the Bradford protein detection method ([@R5]). Control samples were set as 1. Experiments were performed three times in duplicate.

Data analysis {#S12}
-------------

Data were expressed as mean values ± SD of all measurements and compared by Mann Whitney or by Anova test with significance at p\<0.05. Statistical data were obtained using GraphPad software 5.0 (San Diego, CA, USA).
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ABCC6/Abcc6

:   ATP -- binding cassette sub-family C member 6 (human/mouse)

Ank

:   progressive ankylosis protein

Bmp2

:   bone morphogenic protein 2

Enpp1

:   pyrophosphatase/ phosphodiesterase 1

KO

:   knock out

Opn

:   osteopontin

Pi

:   inorganic phosphate

PPi

:   inorganic pyrophosphate

PXE

:   Pseudoxanthoma elasticum

ROS

:   reactive oxygen species

Tnap

:   tissue non-specific alkaline phosphatase

WT

:   wild type

![Dermal fibroblasts cultured from KO (Abcc6^−/−^) and WT (Abcc6^+/+^) mice of 0.5 and 12 months of age and observed by phase contrast microscopy (a). Differences in the proliferation capabilities are related to the age of the animals, but are independent of the genotype as clearly shown in graph (b). Bar = 300 μm.](nihms565005f1){#F1}

![Anion superoxide (O~2~^−^) and hydrogen peroxide (H~2~O~2~) content measured by flow cytometry in dermal fibroblasts cultured from WT (Abcc6^+/+^) and KO (Abcc6^−/−^) mice of 0.5 and 12 months of age. \*p\<0.05, KO vs WT of the same age; \# p\<0.05 0.5 vs 12 months of age within the same genotype.](nihms565005f2){#F2}

![Expression of Bmp2 measured by Western blot in dermal fibroblasts cultured from WT (Abcc6^+/+^) and KO (Abcc6^−/−^) mice of 0.5 and 12 months of age. Data are expressed as mean values ± SD of densitometric analyses were values in cells from WT animals 0.5 month-old were set at 1. A representative Western blot is shown. \*p\<0.05, KO vs WT of the same age; \#\# p\<0.01, 0.5 vs 12 months within the same genotype.](nihms565005f3){#F3}

![Tnap expression and activity were evaluated in dermal fibroblasts cultured from WT (Abcc6^+/+^) and KO (Abcc6^−/−^) mice of 0.5 and 12 months of age. Data are expressed as mean values ± SD of different measurements were values in cells from WT animals 0.5 month-old were set at 1. A representative Western blot is shown. \*p\<0.05, KO vs WT of the same age; \#\# p\<0.01 and \#\#\# p\<0.001, 0.5 vs 12 months within the same genotype.](nihms565005f4){#F4}

![Enpp1 and Ank expression measured by Western blot in dermal fibroblasts cultured from WT (Abcc6^+/+^) and KO (Abcc6^−/−^) mice of 0.5 and 12 months of age. Data are expressed as mean values ± SD of densitometric analyses were values in cells from WT animals 0.5 month-old were set at 1. Representative Western blots are shown. \*\*p\<0.01 KO vs WT of the same age; \#\# p\<0.01 0.5 vs 12 months within the same genotype.](nihms565005f5){#F5}

![Expression of Opn measured by Western blot in dermal fibroblasts cultured from WT (Abcc6^+/+^) and KO (Abcc6^−/−^) mice of 0.5 and 12 months of age. Data are expressed as mean values ± SD of densitometric analyses were values in cells from WT animals 0.5 month-old were set at 1. A representative Western blot is shown. \*p\<0.05 and \*\*p\<0.01 KO vs WT of the same age.](nihms565005f6){#F6}

###### 

Influence of genotype (WT vs KO) and aging (0.5 vs 12 months) on the expression of cellular parameters.

  Parameters   CHANGES INFLUENCED BY         
  ------------ ----------------------- ----- -----
  O~2~         content                 YES   YES
  Bmp2         expression              YES   YES
  Tnap         expression              NO    YES
  activity     YES                     YES   
  Enpp1        expression              NO    YES
  Ank          expression              YES   NO
  Opn          expression              YES   NO
